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An observational study to evaluate the therapeutic efficacy and safety of platelet components 
prepared with the INTERCEPT process
JPY Sim1, RYY Leung2, WC Tsoi3, CK Lee3, CL Lam2, CK Lin3, AKW Lie1
1 Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
2 Division of Haematology, Department of Pathology and Clinical Biochemistry, Queen Mary Hospital, Hong Kong
3 Hong Kong Red Cross Blood Transfusion Service, Hong Kong
Transfusion support is an essential part of haematopoietic stem cell transplant (HSCT). Platelet components for 
transfusion are stored at room temperature as cold temperatures induce aggregation of von Willebrand factor 
receptors and subsequent platelet elimination by liver macrophages. However, storage at room temperature 
increases the risk of bacterial contamination (estimated to be 1/2000 to 1/3000 platelet units). 
 The amotosalen ⁄ UVA-based INTERCEPT Blood System (IBS; Cerus Corporation, Concord CA, US) is one 
pathogen inactivation technology which inactivates pathogen through a photochemical reaction preventing 
DNA replication and RNA transcription. I-PLT (INTERCEPT-treated Platelet) has the further advantage of 
lymphocyte inactivation, obviating the need for gamma-irradiation for transfusion-associated graft-versus-host 
disease (TA-GvHD) prophylaxis in HSCT recipients. IBS has received national registration in France (Afssaps), 
Germany (Paul Ehrlich Institute), and Switzerland (Swissmedic) as well as in other countries. Here we conduct 
a prospective study to evaluate the therapeutic efficacy and safety of I-PLT in Hong Kong Chinese HSCT 
recipients.
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Drug-induced agranulocytosis in Southern Chinese population: a twelve-year retrospective  
study
CW Sing, CL Cheung
Department of Medicine, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong
Introduction: Drug-induced agranulocytosis is a rare but serious adverse drug reaction. There are, however, 
limited studies on the epidemiology of drug-induced agranulocytosis in the Chinese population.
Methods: We performed a descriptive analysis on drug-induced agranulocytosis in Hong Kong. Data were 
obtained from Hong Kong Clinical Data Analysis and Reporting System database. Patients with agranulocytosis 
(ICD-9 code: 288.0) during 2002 to 2012 were investigated. Laboratory data and prescription records were 
reviewed to identify drug-induced cases. 
Results: A total of 215 cases were identiﬁed from the database. The incidence rate was estimated to be 2.58 per 
million people per year. The mean age was 53±20.9 years and male-to-female ratio was 0.71:1. Case fatality rate 
was 7.4% and all the deaths were aged over 60 years. Anti-thyroid drugs (33%) was the most common group of 
causative drugs, in which 62% were derived from carbimazole. Antibiotics were the second most common in 
32.6% of patients with penicillin (34.3%) being the most implicated drug. Anticonvulsants were responsible in 
9.3% of cases, in which phenytoin (65%) was more common than other anticonvulsants. Other causative drugs 
include antipsychotics (clozapine), gout suppressants (allopurinol, colchicine), antiplatelet agent (clopidogrel), 
and iron-chelating agent (deferiprone). 
Conclusion: This is the ﬁrst epidemiological study in Southern Chinese population. Results were comparable to 
studies in other populations.
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